Following on its "quiet filing" for an initial public offeringearlier this month (see BioWorld, Nov. 5), Genta Inc. on Mondaysaid it will offer 2.5 million shares of common stock at aproposed price of $9 to $11 per share.
Genta of San Diego is developing antisense oligonucleotides.Montgomery Securities and Alex. Brown & Sons Inc. areunderwriting the offering.
(c) 1997 American Health Consultants. All rights reserved.